| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transplantation, Heterologous | 345 | 2024 | 2395 | 47.150 |
Why?
|
| Swine | 313 | 2024 | 5998 | 18.260 |
Why?
|
| Graft Rejection | 149 | 2024 | 4492 | 14.060 |
Why?
|
| Animals, Genetically Modified | 152 | 2024 | 1564 | 13.900 |
Why?
|
| Islets of Langerhans Transplantation | 49 | 2024 | 748 | 9.570 |
Why?
|
| Papio | 103 | 2024 | 672 | 9.150 |
Why?
|
| Graft Survival | 90 | 2024 | 3888 | 9.110 |
Why?
|
| Galactosyltransferases | 66 | 2021 | 284 | 8.050 |
Why?
|
| Heart Transplantation | 61 | 2024 | 3301 | 7.350 |
Why?
|
| Kidney Transplantation | 59 | 2024 | 4265 | 7.030 |
Why?
|
| Primates | 51 | 2024 | 522 | 6.960 |
Why?
|
| Organ Transplantation | 34 | 2024 | 1178 | 5.990 |
Why?
|
| Transplants | 17 | 2023 | 209 | 5.530 |
Why?
|
| Sus scrofa | 29 | 2021 | 430 | 4.930 |
Why?
|
| Antigens, Heterophile | 19 | 2023 | 71 | 4.890 |
Why?
|
| Immunosuppressive Agents | 53 | 2024 | 4207 | 4.120 |
Why?
|
| Antibodies, Heterophile | 20 | 2021 | 128 | 3.990 |
Why?
|
| Animals | 410 | 2024 | 169408 | 3.680 |
Why?
|
| Tissue Donors | 28 | 2022 | 2382 | 3.310 |
Why?
|
| Tissue and Organ Procurement | 16 | 2022 | 986 | 3.140 |
Why?
|
| Genetic Engineering | 22 | 2023 | 936 | 3.000 |
Why?
|
| Galactose | 9 | 2023 | 300 | 2.640 |
Why?
|
| CD40 Ligand | 11 | 2024 | 528 | 2.470 |
Why?
|
| Liver Transplantation | 21 | 2022 | 2403 | 2.460 |
Why?
|
| Antibodies | 27 | 2023 | 2422 | 2.450 |
Why?
|
| Brain Death | 9 | 2023 | 359 | 2.430 |
Why?
|
| Corneal Transplantation | 15 | 2019 | 315 | 2.330 |
Why?
|
| Immunoglobulin M | 31 | 2023 | 1528 | 2.300 |
Why?
|
| Disaccharides | 19 | 2015 | 170 | 2.280 |
Why?
|
| Kidney | 35 | 2023 | 7057 | 2.270 |
Why?
|
| Bioprosthesis | 9 | 2019 | 593 | 2.220 |
Why?
|
| Transplantation Immunology | 19 | 2020 | 537 | 2.170 |
Why?
|
| Complement System Proteins | 17 | 2023 | 738 | 1.940 |
Why?
|
| Leukocytes, Mononuclear | 20 | 2023 | 1855 | 1.910 |
Why?
|
| Heart Valve Prosthesis | 9 | 2019 | 1468 | 1.880 |
Why?
|
| Endothelial Cells | 32 | 2023 | 3591 | 1.850 |
Why?
|
| Research | 10 | 2023 | 1981 | 1.840 |
Why?
|
| Transplantation Tolerance | 17 | 2021 | 633 | 1.810 |
Why?
|
| Triiodothyronine | 7 | 2017 | 492 | 1.800 |
Why?
|
| Gene Knockout Techniques | 30 | 2021 | 808 | 1.770 |
Why?
|
| Diabetes Mellitus, Type 1 | 19 | 2024 | 3447 | 1.750 |
Why?
|
| Clinical Trials as Topic | 20 | 2024 | 8055 | 1.740 |
Why?
|
| Blood Coagulation | 22 | 2024 | 1161 | 1.690 |
Why?
|
| Immunoglobulin G | 37 | 2023 | 4568 | 1.610 |
Why?
|
| Heart | 11 | 2024 | 4448 | 1.550 |
Why?
|
| Spleen | 11 | 2014 | 2294 | 1.550 |
Why?
|
| Heart Valves | 5 | 2019 | 284 | 1.510 |
Why?
|
| Models, Animal | 15 | 2020 | 2123 | 1.500 |
Why?
|
| Erythrocyte Transfusion | 8 | 2023 | 575 | 1.440 |
Why?
|
| Mycobacterium bovis | 10 | 2021 | 148 | 1.360 |
Why?
|
| Humans | 351 | 2024 | 768887 | 1.340 |
Why?
|
| ABO Blood-Group System | 9 | 2020 | 381 | 1.340 |
Why?
|
| Thrombomodulin | 6 | 2024 | 107 | 1.330 |
Why?
|
| Antigens | 10 | 2022 | 1444 | 1.320 |
Why?
|
| Erythrocytes | 11 | 2023 | 2421 | 1.260 |
Why?
|
| Immune Tolerance | 16 | 2020 | 2323 | 1.210 |
Why?
|
| Arteries | 8 | 2018 | 1126 | 1.190 |
Why?
|
| Diabetes Mellitus, Experimental | 9 | 2020 | 1124 | 1.180 |
Why?
|
| Complement Activation | 10 | 2020 | 447 | 1.180 |
Why?
|
| Macaca fascicularis | 13 | 2019 | 913 | 1.180 |
Why?
|
| HLA Antigens | 6 | 2023 | 1336 | 1.180 |
Why?
|
| Transplantation, Homologous | 23 | 2024 | 4835 | 1.170 |
Why?
|
| Histocompatibility | 5 | 2021 | 321 | 1.160 |
Why?
|
| Liver Failure, Acute | 2 | 2022 | 182 | 1.150 |
Why?
|
| Histocompatibility Antigens Class I | 9 | 2021 | 1363 | 1.140 |
Why?
|
| Mixed Function Oxygenases | 8 | 2021 | 265 | 1.140 |
Why?
|
| Neuraminic Acids | 5 | 2021 | 16 | 1.120 |
Why?
|
| Cell Transplantation | 5 | 2014 | 475 | 1.120 |
Why?
|
| Inflammation | 19 | 2023 | 10869 | 1.110 |
Why?
|
| Skin Transplantation | 4 | 2023 | 1097 | 1.080 |
Why?
|
| T-Lymphocytes | 26 | 2020 | 10276 | 1.060 |
Why?
|
| Cornea | 9 | 2021 | 1315 | 1.040 |
Why?
|
| Blood Coagulation Disorders | 7 | 2020 | 350 | 1.040 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 5 | 2024 | 37 | 1.040 |
Why?
|
| Buffaloes | 8 | 2021 | 14 | 1.030 |
Why?
|
| Papio hamadryas | 4 | 2019 | 32 | 1.030 |
Why?
|
| Informed Consent | 8 | 2024 | 1010 | 0.970 |
Why?
|
| Patient Selection | 11 | 2024 | 4265 | 0.950 |
Why?
|
| Swine Diseases | 3 | 2019 | 61 | 0.930 |
Why?
|
| Mesenchymal Stem Cells | 7 | 2021 | 1672 | 0.920 |
Why?
|
| Congresses as Topic | 4 | 2017 | 811 | 0.920 |
Why?
|
| History, 20th Century | 15 | 2020 | 2771 | 0.910 |
Why?
|
| Thyroxine | 4 | 2015 | 665 | 0.900 |
Why?
|
| Serum Amyloid A Protein | 4 | 2021 | 128 | 0.890 |
Why?
|
| Blood Platelets | 11 | 2019 | 2479 | 0.860 |
Why?
|
| Carbohydrates | 5 | 2021 | 389 | 0.840 |
Why?
|
| Swine, Miniature | 21 | 2019 | 965 | 0.840 |
Why?
|
| Cytomegalovirus Infections | 7 | 2022 | 839 | 0.840 |
Why?
|
| Consent Forms | 1 | 2022 | 55 | 0.830 |
Why?
|
| Thyroid Hormones | 2 | 2016 | 407 | 0.810 |
Why?
|
| Blood Transfusion | 4 | 2023 | 1309 | 0.810 |
Why?
|
| Thrombocytopenia | 5 | 2022 | 1181 | 0.800 |
Why?
|
| Attitude | 6 | 2022 | 772 | 0.790 |
Why?
|
| Immunity, Cellular | 8 | 2018 | 1560 | 0.780 |
Why?
|
| Hypophosphatemia | 1 | 2022 | 93 | 0.780 |
Why?
|
| Sirolimus | 6 | 2023 | 1540 | 0.780 |
Why?
|
| Histocompatibility Testing | 4 | 2021 | 716 | 0.770 |
Why?
|
| Heart Valve Prosthesis Implantation | 4 | 2019 | 1568 | 0.770 |
Why?
|
| Isoantigens | 3 | 2022 | 562 | 0.760 |
Why?
|
| Islam | 2 | 2022 | 72 | 0.760 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 4 | 2021 | 507 | 0.730 |
Why?
|
| Antilymphocyte Serum | 4 | 2021 | 492 | 0.720 |
Why?
|
| Receptors, Somatotropin | 1 | 2020 | 58 | 0.710 |
Why?
|
| History, 21st Century | 10 | 2020 | 1575 | 0.700 |
Why?
|
| Living Donors | 3 | 2022 | 649 | 0.680 |
Why?
|
| Heart Valve Diseases | 3 | 2019 | 1030 | 0.680 |
Why?
|
| Papio anubis | 4 | 2012 | 23 | 0.660 |
Why?
|
| Burns | 2 | 2023 | 1901 | 0.650 |
Why?
|
| Respiratory Syncytial Virus Infections | 5 | 2024 | 365 | 0.640 |
Why?
|
| Kidney Failure, Chronic | 6 | 2023 | 2493 | 0.640 |
Why?
|
| Hypovolemia | 1 | 2018 | 48 | 0.630 |
Why?
|
| Platelet Count | 4 | 2019 | 787 | 0.620 |
Why?
|
| Transgenes | 3 | 2021 | 1016 | 0.620 |
Why?
|
| Allergy and Immunology | 1 | 2020 | 175 | 0.620 |
Why?
|
| Tissue Preservation | 1 | 2019 | 173 | 0.610 |
Why?
|
| Judaism | 1 | 2018 | 32 | 0.600 |
Why?
|
| Christianity | 1 | 2018 | 53 | 0.600 |
Why?
|
| Animals, Newborn | 8 | 2020 | 2695 | 0.590 |
Why?
|
| Immunity, Humoral | 7 | 2014 | 610 | 0.590 |
Why?
|
| Respiratory Syncytial Virus, Human | 4 | 2024 | 149 | 0.580 |
Why?
|
| Transplantation | 3 | 2017 | 221 | 0.570 |
Why?
|
| Aorta | 12 | 2020 | 2046 | 0.570 |
Why?
|
| Cytotoxicity, Immunologic | 10 | 2023 | 1356 | 0.560 |
Why?
|
| Thorax | 4 | 2024 | 557 | 0.560 |
Why?
|
| Insulin | 10 | 2021 | 6610 | 0.550 |
Why?
|
| Thromboplastin | 8 | 2018 | 288 | 0.550 |
Why?
|
| Endothelium, Vascular | 14 | 2019 | 4428 | 0.550 |
Why?
|
| Hypoplastic Left Heart Syndrome | 2 | 2020 | 595 | 0.540 |
Why?
|
| Platelet Aggregation | 7 | 2017 | 769 | 0.540 |
Why?
|
| Polysaccharides | 3 | 2021 | 1024 | 0.530 |
Why?
|
| Antibodies, Anti-Idiotypic | 4 | 2019 | 355 | 0.530 |
Why?
|
| Tuberculosis | 9 | 2021 | 2029 | 0.520 |
Why?
|
| Fibrinogen | 2 | 2019 | 892 | 0.520 |
Why?
|
| Chimerism | 3 | 2014 | 156 | 0.520 |
Why?
|
| Hormone Replacement Therapy | 4 | 2016 | 756 | 0.520 |
Why?
|
| Religion and Medicine | 2 | 2020 | 161 | 0.520 |
Why?
|
| Adaptive Immunity | 7 | 2020 | 733 | 0.510 |
Why?
|
| Antibodies, Monoclonal | 9 | 2019 | 9264 | 0.510 |
Why?
|
| Islets of Langerhans | 9 | 2021 | 1351 | 0.490 |
Why?
|
| Stromal Cells | 3 | 2011 | 1337 | 0.490 |
Why?
|
| T-Lymphocytes, Regulatory | 8 | 2023 | 3116 | 0.480 |
Why?
|
| Transplantation Chimera | 7 | 2018 | 594 | 0.480 |
Why?
|
| Euthyroid Sick Syndromes | 1 | 2014 | 14 | 0.480 |
Why?
|
| Trisaccharides | 4 | 2012 | 50 | 0.470 |
Why?
|
| Streptozocin | 3 | 2014 | 190 | 0.470 |
Why?
|
| Species Specificity | 10 | 2021 | 2419 | 0.470 |
Why?
|
| Myocardial Stunning | 1 | 2014 | 67 | 0.460 |
Why?
|
| Cells, Cultured | 27 | 2021 | 19023 | 0.460 |
Why?
|
| Lung Transplantation | 2 | 2015 | 1309 | 0.460 |
Why?
|
| B-Lymphocytes | 9 | 2022 | 4794 | 0.460 |
Why?
|
| Heart Defects, Congenital | 6 | 2024 | 4711 | 0.450 |
Why?
|
| Artificial Organs | 1 | 2015 | 149 | 0.450 |
Why?
|
| Gene Expression | 6 | 2021 | 7602 | 0.450 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2014 | 220 | 0.440 |
Why?
|
| Tumor Necrosis Factor-alpha | 10 | 2021 | 4356 | 0.440 |
Why?
|
| C-Peptide | 9 | 2022 | 443 | 0.440 |
Why?
|
| Hepatocytes | 3 | 2017 | 1246 | 0.440 |
Why?
|
| Immunization, Secondary | 4 | 2024 | 373 | 0.440 |
Why?
|
| Culture | 2 | 2016 | 623 | 0.430 |
Why?
|
| Immunity, Innate | 8 | 2020 | 3080 | 0.430 |
Why?
|
| Lymphocytes | 4 | 2019 | 2614 | 0.420 |
Why?
|
| Postoperative Complications | 10 | 2015 | 15889 | 0.410 |
Why?
|
| Liver Failure | 3 | 2012 | 252 | 0.410 |
Why?
|
| Viscera | 2 | 2010 | 138 | 0.410 |
Why?
|
| Corneal Diseases | 3 | 2016 | 535 | 0.410 |
Why?
|
| Flow Cytometry | 16 | 2020 | 5905 | 0.400 |
Why?
|
| N-Acetylgalactosaminyltransferases | 4 | 2021 | 63 | 0.400 |
Why?
|
| Disease Models, Animal | 16 | 2023 | 18366 | 0.400 |
Why?
|
| Blood Coagulation Factors | 4 | 2019 | 371 | 0.390 |
Why?
|
| Isoantibodies | 5 | 2022 | 681 | 0.380 |
Why?
|
| Mycophenolic Acid | 2 | 2012 | 348 | 0.380 |
Why?
|
| Models, Immunological | 2 | 2012 | 518 | 0.380 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2021 | 1510 | 0.380 |
Why?
|
| Lymphocyte Activation | 11 | 2021 | 5505 | 0.380 |
Why?
|
| Cytomegalovirus | 7 | 2022 | 753 | 0.380 |
Why?
|
| Gene Deletion | 4 | 2018 | 2674 | 0.370 |
Why?
|
| P-Selectin | 1 | 2014 | 599 | 0.370 |
Why?
|
| Transplantation, Heterotopic | 5 | 2016 | 175 | 0.370 |
Why?
|
| Thoracic Surgery | 1 | 2017 | 729 | 0.370 |
Why?
|
| Antibodies, Viral | 10 | 2024 | 3216 | 0.370 |
Why?
|
| CD4-Positive T-Lymphocytes | 8 | 2014 | 4413 | 0.360 |
Why?
|
| Endothelium, Corneal | 4 | 2015 | 212 | 0.360 |
Why?
|
| Acidosis | 1 | 2012 | 271 | 0.360 |
Why?
|
| Stem Cell Transplantation | 3 | 2016 | 1602 | 0.360 |
Why?
|
| Histocompatibility Antigens Class II | 6 | 2017 | 1439 | 0.360 |
Why?
|
| Antigens, CD | 9 | 2015 | 4032 | 0.360 |
Why?
|
| Omentum | 5 | 2019 | 168 | 0.350 |
Why?
|
| Cytokines | 9 | 2021 | 7453 | 0.350 |
Why?
|
| Recovery of Function | 2 | 2014 | 2990 | 0.350 |
Why?
|
| Device Removal | 1 | 2015 | 643 | 0.350 |
Why?
|
| Aspartate Aminotransferases | 1 | 2012 | 414 | 0.340 |
Why?
|
| Treatment Outcome | 29 | 2023 | 65485 | 0.340 |
Why?
|
| Prosthesis Failure | 1 | 2015 | 1209 | 0.340 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2015 | 621 | 0.340 |
Why?
|
| Liver | 10 | 2021 | 7579 | 0.340 |
Why?
|
| Blindness | 1 | 2014 | 587 | 0.340 |
Why?
|
| Anti-Inflammatory Agents | 5 | 2023 | 1813 | 0.330 |
Why?
|
| Tissue Engineering | 2 | 2021 | 1893 | 0.330 |
Why?
|
| Anxiety Disorders | 1 | 2021 | 2748 | 0.330 |
Why?
|
| Tissue and Organ Harvesting | 3 | 2019 | 373 | 0.330 |
Why?
|
| Immunomodulation | 2 | 2017 | 549 | 0.330 |
Why?
|
| Boronic Acids | 1 | 2013 | 915 | 0.320 |
Why?
|
| Diabetes Mellitus | 6 | 2016 | 5892 | 0.320 |
Why?
|
| Alanine Transaminase | 1 | 2012 | 606 | 0.320 |
Why?
|
| Antibodies, Neutralizing | 6 | 2024 | 2009 | 0.310 |
Why?
|
| Forecasting | 6 | 2022 | 2946 | 0.300 |
Why?
|
| Time Factors | 20 | 2017 | 40266 | 0.300 |
Why?
|
| Glucose Tolerance Test | 6 | 2014 | 1183 | 0.290 |
Why?
|
| Gastric Dilatation | 1 | 2007 | 3 | 0.290 |
Why?
|
| Operations Research | 1 | 2007 | 22 | 0.290 |
Why?
|
| Pyrazines | 1 | 2013 | 1206 | 0.290 |
Why?
|
| Calcinosis | 2 | 2015 | 1481 | 0.290 |
Why?
|
| Lymphocyte Culture Test, Mixed | 4 | 2020 | 510 | 0.280 |
Why?
|
| Babesia | 1 | 2007 | 29 | 0.280 |
Why?
|
| Hormones | 3 | 2008 | 871 | 0.280 |
Why?
|
| Chemokine CXCL10 | 3 | 2018 | 312 | 0.280 |
Why?
|
| Monkey Diseases | 1 | 2007 | 71 | 0.280 |
Why?
|
| Hematopoiesis | 3 | 2014 | 2059 | 0.270 |
Why?
|
| Thyroid Gland | 1 | 2013 | 1172 | 0.270 |
Why?
|
| Waiting Lists | 4 | 2021 | 779 | 0.270 |
Why?
|
| Immunoglobulins, Intravenous | 2 | 2022 | 667 | 0.270 |
Why?
|
| Public Opinion | 2 | 2021 | 486 | 0.270 |
Why?
|
| Cytotoxicity Tests, Immunologic | 4 | 2007 | 317 | 0.270 |
Why?
|
| Biomedical Research | 4 | 2016 | 3463 | 0.270 |
Why?
|
| Heptanoic Acids | 1 | 2008 | 344 | 0.270 |
Why?
|
| Pancreas | 5 | 2024 | 1700 | 0.270 |
Why?
|
| Cardiology | 1 | 2017 | 1701 | 0.260 |
Why?
|
| Thyroid Nodule | 1 | 2013 | 767 | 0.260 |
Why?
|
| Serum Albumin, Bovine | 2 | 2003 | 320 | 0.260 |
Why?
|
| Vaccines, Combined | 2 | 2023 | 70 | 0.260 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 8 | 2019 | 3814 | 0.260 |
Why?
|
| Babesiosis | 1 | 2007 | 92 | 0.260 |
Why?
|
| Major Histocompatibility Complex | 2 | 2005 | 877 | 0.250 |
Why?
|
| Phagocytosis | 3 | 2019 | 1530 | 0.250 |
Why?
|
| Coronary Thrombosis | 2 | 2008 | 440 | 0.250 |
Why?
|
| Tissue Transplantation | 2 | 2019 | 128 | 0.250 |
Why?
|
| Epitopes | 7 | 2012 | 2529 | 0.250 |
Why?
|
| Glucose | 3 | 2014 | 4352 | 0.250 |
Why?
|
| Hypoglycemia | 1 | 2012 | 895 | 0.250 |
Why?
|
| Pancreas Transplantation | 2 | 2016 | 193 | 0.240 |
Why?
|
| Hemolysis | 2 | 2023 | 417 | 0.230 |
Why?
|
| Membrane Glycoproteins | 2 | 2014 | 3714 | 0.230 |
Why?
|
| Lymphoproliferative Disorders | 4 | 2019 | 529 | 0.230 |
Why?
|
| Immunosorbent Techniques | 1 | 2004 | 174 | 0.230 |
Why?
|
| South Africa | 6 | 2021 | 1872 | 0.230 |
Why?
|
| Biological Evolution | 1 | 2010 | 1078 | 0.230 |
Why?
|
| Tacrolimus | 3 | 2018 | 750 | 0.220 |
Why?
|
| Cebus | 2 | 2020 | 15 | 0.220 |
Why?
|
| Registries | 1 | 2020 | 8384 | 0.220 |
Why?
|
| Tuberculin Test | 3 | 2021 | 205 | 0.220 |
Why?
|
| Cyclophosphamide | 1 | 2009 | 2227 | 0.220 |
Why?
|
| History, 18th Century | 2 | 2015 | 206 | 0.220 |
Why?
|
| Antibody Formation | 5 | 2017 | 1393 | 0.220 |
Why?
|
| Glycoconjugates | 1 | 2003 | 88 | 0.210 |
Why?
|
| Mouth Mucosa | 1 | 2006 | 437 | 0.210 |
Why?
|
| China | 4 | 2023 | 2395 | 0.210 |
Why?
|
| Male | 51 | 2024 | 365249 | 0.210 |
Why?
|
| HIV Infections | 8 | 2016 | 17589 | 0.210 |
Why?
|
| Saimiri | 1 | 2023 | 337 | 0.210 |
Why?
|
| Disseminated Intravascular Coagulation | 3 | 2012 | 187 | 0.200 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 2023 | 86 | 0.200 |
Why?
|
| Platelet Activation | 3 | 2017 | 644 | 0.200 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2016 | 3233 | 0.200 |
Why?
|
| Infant | 11 | 2024 | 36541 | 0.200 |
Why?
|
| Pyrroles | 1 | 2008 | 1126 | 0.200 |
Why?
|
| Resuscitation | 1 | 2006 | 679 | 0.200 |
Why?
|
| Cattle | 5 | 2022 | 3820 | 0.190 |
Why?
|
| Elapid Venoms | 1 | 2021 | 40 | 0.190 |
Why?
|
| Inflammation Mediators | 3 | 2021 | 1890 | 0.190 |
Why?
|
| History, 19th Century | 2 | 2015 | 715 | 0.190 |
Why?
|
| HIV Fusion Inhibitors | 2 | 2016 | 83 | 0.190 |
Why?
|
| Raffinose | 1 | 2021 | 57 | 0.190 |
Why?
|
| Thrombotic Microangiopathies | 2 | 2024 | 124 | 0.190 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 2 | 2014 | 896 | 0.190 |
Why?
|
| Immunization | 4 | 2020 | 1219 | 0.190 |
Why?
|
| Adult | 31 | 2024 | 223818 | 0.190 |
Why?
|
| Antibody Specificity | 2 | 2021 | 1065 | 0.190 |
Why?
|
| Antigens, Bacterial | 3 | 2018 | 1150 | 0.190 |
Why?
|
| General Surgery | 1 | 2012 | 1722 | 0.180 |
Why?
|
| Disulfides | 1 | 2003 | 467 | 0.180 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2016 | 4651 | 0.180 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2021 | 124 | 0.180 |
Why?
|
| Interleukin-6 | 3 | 2021 | 3233 | 0.180 |
Why?
|
| Infant, Newborn | 7 | 2024 | 26394 | 0.180 |
Why?
|
| Iliac Artery | 2 | 2019 | 344 | 0.180 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2002 | 200 | 0.180 |
Why?
|
| Quality of Life | 7 | 2023 | 13510 | 0.180 |
Why?
|
| Chemokine CCL2 | 2 | 2021 | 606 | 0.180 |
Why?
|
| Organ Preservation Solutions | 1 | 2021 | 104 | 0.180 |
Why?
|
| Female | 45 | 2024 | 397464 | 0.180 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2021 | 115 | 0.180 |
Why?
|
| Immunoglobulins | 4 | 2017 | 855 | 0.180 |
Why?
|
| Renin | 1 | 2023 | 648 | 0.180 |
Why?
|
| Blood Glucose | 9 | 2022 | 6434 | 0.180 |
Why?
|
| Homeostasis | 1 | 2011 | 3348 | 0.180 |
Why?
|
| Immunologic Memory | 4 | 2018 | 1378 | 0.180 |
Why?
|
| Macrophages | 1 | 2015 | 5800 | 0.170 |
Why?
|
| Neoplasms | 3 | 2019 | 22390 | 0.170 |
Why?
|
| Lectins, C-Type | 2 | 2014 | 593 | 0.170 |
Why?
|
| Graft vs Host Disease | 4 | 2007 | 3048 | 0.170 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2010 | 3408 | 0.170 |
Why?
|
| Anti-HIV Agents | 2 | 2014 | 4576 | 0.170 |
Why?
|
| Inguinal Canal | 1 | 2020 | 71 | 0.170 |
Why?
|
| Thyroid Neoplasms | 1 | 2013 | 2360 | 0.170 |
Why?
|
| Tissue Survival | 3 | 2020 | 120 | 0.170 |
Why?
|
| E-Selectin | 2 | 2021 | 578 | 0.170 |
Why?
|
| Societies, Medical | 4 | 2016 | 3967 | 0.170 |
Why?
|
| Allopurinol | 1 | 2021 | 202 | 0.170 |
Why?
|
| C-Reactive Protein | 5 | 2018 | 3858 | 0.170 |
Why?
|
| Primary Prevention | 1 | 2007 | 1187 | 0.170 |
Why?
|
| Interferon-gamma | 6 | 2018 | 3163 | 0.170 |
Why?
|
| Histocompatibility Antigens | 2 | 2014 | 479 | 0.170 |
Why?
|
| Plant Extracts | 1 | 2003 | 499 | 0.170 |
Why?
|
| Research Subjects | 1 | 2021 | 249 | 0.170 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2021 | 692 | 0.170 |
Why?
|
| Nitrogen | 1 | 2021 | 345 | 0.170 |
Why?
|
| Virus Activation | 3 | 2009 | 324 | 0.160 |
Why?
|
| Young Adult | 15 | 2024 | 60110 | 0.160 |
Why?
|
| Kidney Diseases | 2 | 2023 | 2100 | 0.160 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 588 | 0.160 |
Why?
|
| Calcium | 2 | 2022 | 5792 | 0.160 |
Why?
|
| Thymus Gland | 6 | 2018 | 1266 | 0.160 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 5 | 2006 | 5716 | 0.160 |
Why?
|
| Phosphates | 1 | 2022 | 765 | 0.160 |
Why?
|
| Viral Fusion Proteins | 3 | 2024 | 100 | 0.160 |
Why?
|
| Adenosine | 2 | 2021 | 822 | 0.160 |
Why?
|
| Polymerase Chain Reaction | 4 | 2005 | 6085 | 0.160 |
Why?
|
| Insulin-Secreting Cells | 2 | 2016 | 899 | 0.160 |
Why?
|
| Theology | 1 | 2018 | 4 | 0.160 |
Why?
|
| Portal Vein | 2 | 2014 | 435 | 0.160 |
Why?
|
| Sepsis | 1 | 2012 | 2609 | 0.150 |
Why?
|
| Glutathione | 1 | 2021 | 589 | 0.150 |
Why?
|
| Histones | 2 | 2020 | 2603 | 0.150 |
Why?
|
| Ethics Committees, Research | 1 | 2020 | 196 | 0.150 |
Why?
|
| Receptors, Complement | 1 | 2019 | 254 | 0.150 |
Why?
|
| Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing) | 1 | 2018 | 8 | 0.150 |
Why?
|
| Dihydroorotase | 1 | 2018 | 8 | 0.150 |
Why?
|
| Technology | 1 | 2021 | 296 | 0.150 |
Why?
|
| Aspartate Carbamoyltransferase | 1 | 2018 | 18 | 0.150 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2020 | 224 | 0.150 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2014 | 2763 | 0.150 |
Why?
|
| Sclerotherapy | 1 | 2019 | 183 | 0.150 |
Why?
|
| Varicellovirus | 2 | 2008 | 7 | 0.150 |
Why?
|
| Pluripotent Stem Cells | 2 | 2015 | 810 | 0.150 |
Why?
|
| Cell Proliferation | 10 | 2016 | 10486 | 0.150 |
Why?
|
| Financial Support | 1 | 2019 | 116 | 0.150 |
Why?
|
| Renin-Angiotensin System | 1 | 2023 | 736 | 0.150 |
Why?
|
| Specialties, Surgical | 1 | 2003 | 393 | 0.150 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2004 | 843 | 0.150 |
Why?
|
| Life Support Care | 1 | 2019 | 226 | 0.150 |
Why?
|
| Pleurodesis | 1 | 2018 | 49 | 0.150 |
Why?
|
| Talc | 1 | 2018 | 48 | 0.150 |
Why?
|
| Varicose Veins | 1 | 2019 | 158 | 0.150 |
Why?
|
| Thromboxane-A Synthase | 1 | 2017 | 34 | 0.150 |
Why?
|
| NF-kappa B | 3 | 2021 | 2492 | 0.140 |
Why?
|
| Lipoproteins | 2 | 2014 | 880 | 0.140 |
Why?
|
| Gene Knock-In Techniques | 1 | 2019 | 422 | 0.140 |
Why?
|
| Mammals | 1 | 2023 | 1136 | 0.140 |
Why?
|
| Tissue Distribution | 3 | 2010 | 2299 | 0.140 |
Why?
|
| Skin, Artificial | 1 | 2018 | 89 | 0.140 |
Why?
|
| Blood Group Antigens | 1 | 2019 | 185 | 0.140 |
Why?
|
| Immunoglobulin A | 1 | 2021 | 992 | 0.140 |
Why?
|
| Macaca mulatta | 7 | 2021 | 2365 | 0.140 |
Why?
|
| Cyclooxygenase 2 | 1 | 2019 | 599 | 0.140 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2017 | 105 | 0.140 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2019 | 348 | 0.140 |
Why?
|
| Immunoassay | 1 | 2020 | 746 | 0.140 |
Why?
|
| Pleural Effusion, Malignant | 1 | 2018 | 108 | 0.140 |
Why?
|
| United States | 11 | 2023 | 73180 | 0.140 |
Why?
|
| Phenotype | 7 | 2018 | 16735 | 0.140 |
Why?
|
| Anniversaries and Special Events | 1 | 2017 | 97 | 0.140 |
Why?
|
| Risk Assessment | 4 | 2021 | 24330 | 0.140 |
Why?
|
| International Cooperation | 3 | 2014 | 1436 | 0.140 |
Why?
|
| Mice, SCID | 3 | 2014 | 2631 | 0.140 |
Why?
|
| Angiopoietin-1 | 1 | 2017 | 134 | 0.140 |
Why?
|
| Heme Oxygenase-1 | 1 | 2019 | 364 | 0.140 |
Why?
|
| Child | 15 | 2024 | 80969 | 0.130 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 5520 | 0.130 |
Why?
|
| Middle Aged | 26 | 2024 | 223740 | 0.130 |
Why?
|
| Subcutaneous Fat | 1 | 2020 | 403 | 0.130 |
Why?
|
| Thrombin | 3 | 2013 | 600 | 0.130 |
Why?
|
| Single-Blind Method | 4 | 2021 | 1585 | 0.130 |
Why?
|
| Risk Factors | 10 | 2021 | 74971 | 0.130 |
Why?
|
| Mice, Inbred NOD | 2 | 2014 | 1839 | 0.130 |
Why?
|
| Attitude of Health Personnel | 2 | 2020 | 3925 | 0.130 |
Why?
|
| Ganciclovir | 2 | 2009 | 256 | 0.130 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2017 | 318 | 0.130 |
Why?
|
| Genetic Techniques | 1 | 2019 | 428 | 0.130 |
Why?
|
| Injections, Intramuscular | 3 | 2023 | 556 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 2 | 2013 | 7460 | 0.130 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 692 | 0.130 |
Why?
|
| Parents | 2 | 2020 | 3597 | 0.130 |
Why?
|
| Colony-Forming Units Assay | 2 | 2006 | 351 | 0.130 |
Why?
|
| Paris | 1 | 2015 | 41 | 0.130 |
Why?
|
| Keratoplasty, Penetrating | 1 | 2016 | 143 | 0.130 |
Why?
|
| Angiopoietin-2 | 1 | 2017 | 185 | 0.130 |
Why?
|
| Thromboembolism | 1 | 2002 | 1004 | 0.130 |
Why?
|
| Genotype | 4 | 2018 | 13048 | 0.130 |
Why?
|
| Cyclohexanes | 1 | 2016 | 152 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 2 | 2010 | 1608 | 0.130 |
Why?
|
| Acidic Glycosphingolipids | 1 | 2015 | 3 | 0.130 |
Why?
|
| Glucuronidase | 1 | 2017 | 205 | 0.120 |
Why?
|
| Rodentia | 2 | 2014 | 262 | 0.120 |
Why?
|
| History, 17th Century | 1 | 2015 | 108 | 0.120 |
Why?
|
| Apyrase | 2 | 2015 | 376 | 0.120 |
Why?
|
| Autoantibodies | 1 | 2004 | 2126 | 0.120 |
Why?
|
| Interleukin-1beta | 2 | 2021 | 1027 | 0.120 |
Why?
|
| Respiratory Tract Infections | 1 | 2023 | 1014 | 0.120 |
Why?
|
| Bone Marrow Transplantation | 1 | 2003 | 2709 | 0.120 |
Why?
|
| Disease Reservoirs | 1 | 2015 | 123 | 0.120 |
Why?
|
| Risk Adjustment | 1 | 2019 | 603 | 0.120 |
Why?
|
| Drug Therapy, Combination | 4 | 2021 | 6320 | 0.120 |
Why?
|
| Pan troglodytes | 1 | 2015 | 224 | 0.120 |
Why?
|
| Gammaherpesvirinae | 2 | 2005 | 27 | 0.120 |
Why?
|
| Influenza Vaccines | 1 | 2022 | 780 | 0.120 |
Why?
|
| Ileum | 1 | 2017 | 558 | 0.120 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2017 | 423 | 0.120 |
Why?
|
| Psychology | 1 | 2016 | 354 | 0.120 |
Why?
|
| Survival Analysis | 3 | 2018 | 10115 | 0.120 |
Why?
|
| Immunoglobulin E | 1 | 2021 | 1506 | 0.120 |
Why?
|
| Serologic Tests | 1 | 2016 | 383 | 0.120 |
Why?
|
| Monocytes | 3 | 2015 | 2603 | 0.120 |
Why?
|
| Rotator Cuff | 1 | 2017 | 348 | 0.110 |
Why?
|
| Blood | 2 | 2015 | 597 | 0.110 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 1073 | 0.110 |
Why?
|
| Chemokines | 2 | 2018 | 963 | 0.110 |
Why?
|
| Ritonavir | 1 | 2016 | 332 | 0.110 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2014 | 139 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2017 | 706 | 0.110 |
Why?
|
| Mycobacterium Infections | 1 | 2014 | 122 | 0.110 |
Why?
|
| Interleukin-17 | 2 | 2017 | 925 | 0.110 |
Why?
|
| Product Packaging | 1 | 2013 | 26 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 2063 | 0.110 |
Why?
|
| Inflammasomes | 1 | 2019 | 540 | 0.110 |
Why?
|
| rho-Associated Kinases | 1 | 2015 | 285 | 0.110 |
Why?
|
| Dendritic Cells | 2 | 2016 | 2748 | 0.110 |
Why?
|
| Virus Replication | 3 | 2016 | 2458 | 0.110 |
Why?
|
| Immune System | 2 | 2011 | 800 | 0.110 |
Why?
|
| HIV-1 | 4 | 2006 | 6963 | 0.110 |
Why?
|
| Radiation, Ionizing | 1 | 2014 | 252 | 0.110 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 11119 | 0.110 |
Why?
|
| HIV Protease Inhibitors | 1 | 2016 | 432 | 0.110 |
Why?
|
| Cadaver | 1 | 2018 | 1366 | 0.110 |
Why?
|
| Retroviridae | 2 | 2008 | 849 | 0.110 |
Why?
|
| Donor Selection | 1 | 2015 | 240 | 0.110 |
Why?
|
| Motivation | 1 | 2023 | 2030 | 0.110 |
Why?
|
| T-Box Domain Proteins | 1 | 2016 | 472 | 0.110 |
Why?
|
| Hamartoma | 1 | 2015 | 236 | 0.100 |
Why?
|
| Anemia, Sickle Cell | 1 | 2021 | 1065 | 0.100 |
Why?
|
| Amides | 1 | 2015 | 452 | 0.100 |
Why?
|
| Interleukin-2 | 3 | 2012 | 1895 | 0.100 |
Why?
|
| Spermatogonia | 1 | 2012 | 30 | 0.100 |
Why?
|
| Middle East | 1 | 2013 | 233 | 0.100 |
Why?
|
| Societies, Scientific | 1 | 2014 | 223 | 0.100 |
Why?
|
| Wound Healing | 3 | 2017 | 2815 | 0.100 |
Why?
|
| Cell Division | 5 | 2010 | 4478 | 0.100 |
Why?
|
| London | 1 | 2012 | 233 | 0.100 |
Why?
|
| Tobacco Industry | 1 | 2013 | 138 | 0.100 |
Why?
|
| Needs Assessment | 1 | 2018 | 1142 | 0.100 |
Why?
|
| Genes, MHC Class II | 1 | 2013 | 433 | 0.100 |
Why?
|
| Laser Therapy | 1 | 2019 | 1110 | 0.100 |
Why?
|
| Regenerative Medicine | 1 | 2016 | 311 | 0.100 |
Why?
|
| Endonucleases | 1 | 2015 | 371 | 0.100 |
Why?
|
| Extracellular Matrix | 3 | 2021 | 1739 | 0.100 |
Why?
|
| Myocardium | 5 | 2008 | 4790 | 0.100 |
Why?
|
| Age Factors | 6 | 2024 | 18454 | 0.100 |
Why?
|
| Glucagon | 2 | 2014 | 534 | 0.100 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2021 | 1893 | 0.100 |
Why?
|
| Colitis, Collagenous | 1 | 2012 | 25 | 0.100 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2007 | 3253 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2019 | 2941 | 0.100 |
Why?
|
| Cyclosporine | 1 | 2014 | 777 | 0.100 |
Why?
|
| Infusions, Intravenous | 3 | 2006 | 2231 | 0.100 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 2 | 2013 | 306 | 0.100 |
Why?
|
| Endogenous Retroviruses | 1 | 2013 | 112 | 0.100 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2019 | 1024 | 0.100 |
Why?
|
| Fatal Outcome | 2 | 2007 | 1836 | 0.100 |
Why?
|
| Cercopithecidae | 2 | 2020 | 22 | 0.100 |
Why?
|
| Attitude to Health | 1 | 2020 | 2025 | 0.100 |
Why?
|
| Marketing | 1 | 2013 | 224 | 0.090 |
Why?
|
| Glycosyltransferases | 2 | 2018 | 114 | 0.090 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 12093 | 0.090 |
Why?
|
| Heart Failure | 1 | 2016 | 11879 | 0.090 |
Why?
|
| Lymphopenia | 1 | 2014 | 299 | 0.090 |
Why?
|
| Adolescent | 12 | 2024 | 89247 | 0.090 |
Why?
|
| MicroRNAs | 2 | 2018 | 3811 | 0.090 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2015 | 2203 | 0.090 |
Why?
|
| Nuclear Proteins | 2 | 2018 | 5803 | 0.090 |
Why?
|
| Rheumatic Heart Disease | 1 | 2012 | 164 | 0.090 |
Why?
|
| Brain | 3 | 2023 | 27476 | 0.090 |
Why?
|
| Sweden | 1 | 2014 | 1382 | 0.090 |
Why?
|
| Forssman Antigen | 1 | 2010 | 6 | 0.090 |
Why?
|
| Interdisciplinary Communication | 1 | 2016 | 937 | 0.090 |
Why?
|
| Australia | 1 | 2014 | 1265 | 0.090 |
Why?
|
| Intestine, Small | 2 | 2009 | 1218 | 0.090 |
Why?
|
| Triazoles | 1 | 2016 | 904 | 0.090 |
Why?
|
| Arthroscopy | 1 | 2017 | 972 | 0.090 |
Why?
|
| Arginine | 2 | 2014 | 932 | 0.090 |
Why?
|
| Killer Cells, Natural | 3 | 2023 | 2211 | 0.090 |
Why?
|
| Host vs Graft Reaction | 1 | 2009 | 13 | 0.090 |
Why?
|
| Hemagglutination | 1 | 2009 | 32 | 0.080 |
Why?
|
| Autoantigens | 1 | 2014 | 891 | 0.080 |
Why?
|
| Liver Function Tests | 1 | 2011 | 526 | 0.080 |
Why?
|
| Animals, Wild | 2 | 2020 | 78 | 0.080 |
Why?
|
| Blood Banks | 1 | 2010 | 108 | 0.080 |
Why?
|
| Acute Disease | 5 | 2008 | 7245 | 0.080 |
Why?
|
| Public Health | 1 | 2022 | 2680 | 0.080 |
Why?
|
| Aorta, Abdominal | 1 | 2012 | 627 | 0.080 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2019 | 3683 | 0.080 |
Why?
|
| Testis | 1 | 2012 | 784 | 0.080 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2020 | 1930 | 0.080 |
Why?
|
| Renal Dialysis | 1 | 2018 | 1789 | 0.080 |
Why?
|
| Immunophenotyping | 3 | 2016 | 1866 | 0.080 |
Why?
|
| Plasmapheresis | 1 | 2009 | 206 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 3438 | 0.080 |
Why?
|
| Haplotypes | 2 | 2006 | 2725 | 0.080 |
Why?
|
| Lymph Nodes | 2 | 2014 | 3473 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 2911 | 0.080 |
Why?
|
| DNA Primers | 3 | 2019 | 2827 | 0.080 |
Why?
|
| Career Choice | 1 | 2015 | 769 | 0.080 |
Why?
|
| DNA | 2 | 2020 | 7214 | 0.080 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 2 | 2020 | 306 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 12252 | 0.080 |
Why?
|
| Treatment Failure | 2 | 2017 | 2663 | 0.080 |
Why?
|
| Reverse Transcriptase Inhibitors | 2 | 2016 | 622 | 0.080 |
Why?
|
| Spermatozoa | 1 | 2012 | 631 | 0.080 |
Why?
|
| Mice | 9 | 2019 | 82074 | 0.080 |
Why?
|
| Complement Hemolytic Activity Assay | 2 | 2007 | 9 | 0.080 |
Why?
|
| Perfusion | 2 | 2020 | 1402 | 0.080 |
Why?
|
| Oligosaccharides | 1 | 2010 | 407 | 0.070 |
Why?
|
| AIDS Vaccines | 1 | 2014 | 900 | 0.070 |
Why?
|
| DNA, Viral | 6 | 2004 | 2205 | 0.070 |
Why?
|
| Aged | 13 | 2024 | 171790 | 0.070 |
Why?
|
| Liver Diseases | 1 | 2016 | 1305 | 0.070 |
Why?
|
| Peritoneal Cavity | 1 | 2008 | 135 | 0.070 |
Why?
|
| Bone Marrow Cells | 2 | 2006 | 2414 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2017 | 2884 | 0.070 |
Why?
|
| Lactic Acid | 1 | 2012 | 1140 | 0.070 |
Why?
|
| Adipose Tissue | 2 | 2012 | 3335 | 0.070 |
Why?
|
| Hemoglobins | 2 | 2003 | 1531 | 0.070 |
Why?
|
| Signal Transduction | 5 | 2021 | 23652 | 0.070 |
Why?
|
| Cell Survival | 4 | 2012 | 5794 | 0.070 |
Why?
|
| Carotid Arteries | 1 | 2011 | 943 | 0.070 |
Why?
|
| Methylprednisolone | 1 | 2008 | 387 | 0.070 |
Why?
|
| RNA, Messenger | 5 | 2014 | 12809 | 0.070 |
Why?
|
| Alleles | 3 | 2016 | 6901 | 0.070 |
Why?
|
| Regeneration | 3 | 2016 | 1524 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 22381 | 0.070 |
Why?
|
| Transplantation, Autologous | 1 | 2012 | 2126 | 0.070 |
Why?
|
| Anorexia | 1 | 2007 | 152 | 0.070 |
Why?
|
| Prognosis | 2 | 2018 | 30044 | 0.070 |
Why?
|
| Herpesviridae Infections | 2 | 2005 | 269 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 3450 | 0.070 |
Why?
|
| Syndrome | 1 | 2012 | 3274 | 0.070 |
Why?
|
| Fasting | 2 | 2014 | 1610 | 0.070 |
Why?
|
| Immune Sera | 1 | 2006 | 605 | 0.060 |
Why?
|
| Hepatectomy | 1 | 2009 | 588 | 0.060 |
Why?
|
| Galactosidases | 1 | 2005 | 55 | 0.060 |
Why?
|
| Anxiety | 1 | 2021 | 4677 | 0.060 |
Why?
|
| Coculture Techniques | 3 | 2015 | 1342 | 0.060 |
Why?
|
| Physicians | 2 | 2020 | 4607 | 0.060 |
Why?
|
| Endovascular Procedures | 1 | 2019 | 2218 | 0.060 |
Why?
|
| Focus Groups | 2 | 2022 | 1461 | 0.060 |
Why?
|
| Vaccination | 3 | 2024 | 3436 | 0.060 |
Why?
|
| Cell Culture Techniques | 1 | 2012 | 1667 | 0.060 |
Why?
|
| Carbohydrate Sequence | 1 | 2005 | 411 | 0.060 |
Why?
|
| Diarrhea | 1 | 2012 | 1319 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 3724 | 0.060 |
Why?
|
| Protein Binding | 3 | 2019 | 9344 | 0.060 |
Why?
|
| Skin | 1 | 2018 | 4507 | 0.060 |
Why?
|
| Doxycycline | 1 | 2007 | 349 | 0.060 |
Why?
|
| Periodicals as Topic | 1 | 2016 | 1470 | 0.060 |
Why?
|
| Adoptive Transfer | 2 | 2010 | 824 | 0.060 |
Why?
|
| Weaning | 1 | 2005 | 103 | 0.060 |
Why?
|
| Hospital Mortality | 1 | 2019 | 5369 | 0.060 |
Why?
|
| Microspheres | 1 | 2008 | 789 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6546 | 0.060 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2011 | 1803 | 0.060 |
Why?
|
| Microcirculation | 2 | 2008 | 1281 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2022 | 41800 | 0.060 |
Why?
|
| Protein C | 1 | 2024 | 134 | 0.060 |
Why?
|
| Gene Targeting | 1 | 2007 | 841 | 0.060 |
Why?
|
| Splenectomy | 1 | 2005 | 392 | 0.060 |
Why?
|
| Incidence | 3 | 2023 | 21545 | 0.060 |
Why?
|
| Prosthesis Design | 1 | 2011 | 2126 | 0.060 |
Why?
|
| Homozygote | 1 | 2009 | 1779 | 0.060 |
Why?
|
| Hypothermia | 1 | 2006 | 188 | 0.060 |
Why?
|
| Rabbits | 1 | 2010 | 4774 | 0.060 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 2006 | 306 | 0.060 |
Why?
|
| Hemodynamics | 1 | 2014 | 4199 | 0.060 |
Why?
|
| Trans-Activators | 1 | 2013 | 2858 | 0.060 |
Why?
|
| Sulfoxides | 1 | 2003 | 47 | 0.060 |
Why?
|
| Receptors, CCR5 | 2 | 2003 | 491 | 0.050 |
Why?
|
| Apoptosis | 5 | 2019 | 9528 | 0.050 |
Why?
|
| Nuclear Transfer Techniques | 2 | 2016 | 61 | 0.050 |
Why?
|
| Pyridines | 1 | 2015 | 2896 | 0.050 |
Why?
|
| Garlic | 1 | 2003 | 28 | 0.050 |
Why?
|
| Body Weight | 2 | 2020 | 4628 | 0.050 |
Why?
|
| Health | 1 | 2006 | 398 | 0.050 |
Why?
|
| Models, Biological | 1 | 2020 | 9499 | 0.050 |
Why?
|
| Immunodominant Epitopes | 1 | 2004 | 244 | 0.050 |
Why?
|
| Heart-Lung Transplantation | 1 | 2004 | 87 | 0.050 |
Why?
|
| Dipyridamole | 1 | 2003 | 143 | 0.050 |
Why?
|
| Heart Diseases | 1 | 2016 | 2819 | 0.050 |
Why?
|
| Consensus | 2 | 2014 | 3214 | 0.050 |
Why?
|
| Cefoxitin | 1 | 2023 | 36 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 5801 | 0.050 |
Why?
|
| Inulin | 1 | 2023 | 67 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2002 | 2574 | 0.050 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2022 | 48 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2015 | 9682 | 0.050 |
Why?
|
| HIV Core Protein p24 | 1 | 2003 | 247 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 10778 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2006 | 725 | 0.050 |
Why?
|
| World Health Organization | 1 | 2009 | 1327 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2003 | 412 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3116 | 0.050 |
Why?
|
| Thrombosis | 2 | 2007 | 2956 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3239 | 0.050 |
Why?
|
| Hematocrit | 1 | 2003 | 623 | 0.050 |
Why?
|
| Thailand | 1 | 2003 | 288 | 0.050 |
Why?
|
| Fatty Liver | 1 | 2008 | 810 | 0.050 |
Why?
|
| Leukocytes | 3 | 2008 | 2034 | 0.050 |
Why?
|
| False Negative Reactions | 1 | 2003 | 575 | 0.050 |
Why?
|
| Immunoconjugates | 1 | 2009 | 976 | 0.050 |
Why?
|
| Endoscopy, Digestive System | 2 | 2016 | 358 | 0.050 |
Why?
|
| Bacteria | 1 | 2012 | 2219 | 0.050 |
Why?
|
| Gastrointestinal Tract | 1 | 2008 | 839 | 0.050 |
Why?
|
| Neurons | 2 | 2011 | 9524 | 0.050 |
Why?
|
| Vaccines, Inactivated | 1 | 2022 | 186 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2017 | 4755 | 0.050 |
Why?
|
| Retrospective Studies | 5 | 2019 | 81892 | 0.050 |
Why?
|
| AIDS Serodiagnosis | 1 | 2003 | 220 | 0.050 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2021 | 342 | 0.050 |
Why?
|
| Proviruses | 1 | 2003 | 320 | 0.050 |
Why?
|
| Perissodactyla | 1 | 2020 | 5 | 0.050 |
Why?
|
| Adiponectin | 1 | 2007 | 1117 | 0.050 |
Why?
|
| Lung | 4 | 2022 | 10097 | 0.050 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 15955 | 0.040 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2007 | 1903 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 2024 | 680 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 12563 | 0.040 |
Why?
|
| Lymphoid Tissue | 1 | 2002 | 446 | 0.040 |
Why?
|
| Cell Degranulation | 1 | 2021 | 277 | 0.040 |
Why?
|
| beta 2-Microglobulin | 1 | 2021 | 330 | 0.040 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2004 | 746 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2004 | 2475 | 0.040 |
Why?
|
| Proteinuria | 1 | 2023 | 610 | 0.040 |
Why?
|
| Gases | 1 | 2021 | 204 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2004 | 1229 | 0.040 |
Why?
|
| Anticoagulants | 2 | 2014 | 4850 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2013 | 6001 | 0.040 |
Why?
|
| Antimalarials | 1 | 2007 | 908 | 0.040 |
Why?
|
| Ovalbumin | 1 | 2002 | 677 | 0.040 |
Why?
|
| Elephants | 1 | 2020 | 41 | 0.040 |
Why?
|
| Base Sequence | 3 | 2012 | 12430 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2013 | 8742 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2021 | 867 | 0.040 |
Why?
|
| Mexico | 1 | 2002 | 769 | 0.040 |
Why?
|
| Angiotensin II | 1 | 2023 | 844 | 0.040 |
Why?
|
| Receptors, Chemokine | 1 | 2003 | 652 | 0.040 |
Why?
|
| Cell Differentiation | 3 | 2012 | 11684 | 0.040 |
Why?
|
| Transplantation Conditioning | 2 | 2003 | 1601 | 0.040 |
Why?
|
| Platyrrhini | 1 | 2019 | 5 | 0.040 |
Why?
|
| Heart-Assist Devices | 1 | 2010 | 1292 | 0.040 |
Why?
|
| Fracture Healing | 1 | 2002 | 448 | 0.040 |
Why?
|
| Limbus Corneae | 1 | 2021 | 144 | 0.040 |
Why?
|
| Aged, 80 and over | 5 | 2024 | 59738 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 4363 | 0.040 |
Why?
|
| Reference Values | 1 | 2006 | 4941 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2021 | 4148 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2008 | 2258 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2003 | 1421 | 0.040 |
Why?
|
| Neutralization Tests | 1 | 2020 | 739 | 0.040 |
Why?
|
| Viral Load | 4 | 2016 | 3398 | 0.040 |
Why?
|
| Religion and Psychology | 1 | 2020 | 180 | 0.040 |
Why?
|
| Ethics, Research | 1 | 2020 | 178 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2009 | 3047 | 0.040 |
Why?
|
| Potassium | 1 | 2023 | 1319 | 0.040 |
Why?
|
| Macaca | 1 | 2020 | 417 | 0.040 |
Why?
|
| Intention to Treat Analysis | 1 | 2019 | 417 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2002 | 1095 | 0.040 |
Why?
|
| Education, Medical | 1 | 2010 | 1742 | 0.040 |
Why?
|
| Vaccines, Synthetic | 1 | 2020 | 622 | 0.040 |
Why?
|
| Monitoring, Physiologic | 1 | 2005 | 1796 | 0.040 |
Why?
|
| Prevalence | 2 | 2013 | 15875 | 0.040 |
Why?
|
| Aldosterone | 1 | 2023 | 881 | 0.040 |
Why?
|
| Aging | 2 | 2007 | 8765 | 0.040 |
Why?
|
| Sodium | 1 | 2023 | 1597 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2022 | 999 | 0.040 |
Why?
|
| Cryopreservation | 1 | 2002 | 733 | 0.040 |
Why?
|
| Granzymes | 2 | 2013 | 278 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2002 | 1209 | 0.040 |
Why?
|
| HIV Seropositivity | 1 | 2003 | 967 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2009 | 3069 | 0.030 |
Why?
|
| Tuberculin | 1 | 2016 | 64 | 0.030 |
Why?
|
| Lymphocyte Count | 2 | 2014 | 793 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 2019 | 963 | 0.030 |
Why?
|
| Cumulus Cells | 1 | 2016 | 22 | 0.030 |
Why?
|
| Sesquiterpenes | 1 | 2017 | 177 | 0.030 |
Why?
|
| Animals, Inbred Strains | 1 | 2016 | 13 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2002 | 1252 | 0.030 |
Why?
|
| Necrosis | 2 | 2013 | 1621 | 0.030 |
Why?
|
| Epoprostenol | 1 | 2017 | 246 | 0.030 |
Why?
|
| Rats | 1 | 2012 | 23847 | 0.030 |
Why?
|
| Protective Agents | 1 | 2017 | 150 | 0.030 |
Why?
|
| Serum | 1 | 2017 | 207 | 0.030 |
Why?
|
| HIV Antibodies | 1 | 2003 | 1341 | 0.030 |
Why?
|
| Microscopy | 1 | 2021 | 909 | 0.030 |
Why?
|
| Follow-Up Studies | 4 | 2021 | 39394 | 0.030 |
Why?
|
| Child Development | 1 | 2007 | 2337 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2018 | 14751 | 0.030 |
Why?
|
| Proteins | 2 | 2008 | 6011 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2015 | 6512 | 0.030 |
Why?
|
| Catheters, Indwelling | 1 | 2018 | 436 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 2 | 2013 | 1625 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2019 | 1524 | 0.030 |
Why?
|
| Fibroblasts | 2 | 2016 | 4178 | 0.030 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 2014 | 48 | 0.030 |
Why?
|
| Logistic Models | 2 | 2020 | 13317 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2024 | 42684 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2016 | 290 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2023 | 1672 | 0.030 |
Why?
|
| Chemokine CXCL9 | 1 | 2014 | 136 | 0.030 |
Why?
|
| Reoperation | 1 | 2005 | 4342 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2015 | 254 | 0.030 |
Why?
|
| Genes, Synthetic | 1 | 2014 | 88 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2002 | 1813 | 0.030 |
Why?
|
| Vaccines | 1 | 2023 | 842 | 0.030 |
Why?
|
| Cell Separation | 1 | 2020 | 1728 | 0.030 |
Why?
|
| Binding Sites, Antibody | 1 | 2014 | 340 | 0.030 |
Why?
|
| Reperfusion Injury | 1 | 2020 | 1036 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2014 | 3744 | 0.030 |
Why?
|
| Biopsy | 2 | 2016 | 6805 | 0.030 |
Why?
|
| Reproduction | 1 | 2018 | 646 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2015 | 8317 | 0.030 |
Why?
|
| Fatigue | 1 | 2020 | 1557 | 0.030 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2014 | 424 | 0.030 |
Why?
|
| Tetrazolium Salts | 1 | 2012 | 92 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2006 | 5150 | 0.030 |
Why?
|
| Integrin beta3 | 1 | 2013 | 120 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2004 | 9564 | 0.030 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2014 | 299 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2008 | 8095 | 0.030 |
Why?
|
| Ristocetin | 1 | 2012 | 26 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2007 | 3982 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2019 | 951 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2002 | 3414 | 0.030 |
Why?
|
| STAT5 Transcription Factor | 1 | 2013 | 268 | 0.030 |
Why?
|
| Headache | 1 | 2020 | 1263 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2019 | 1741 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 17629 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2017 | 1830 | 0.030 |
Why?
|
| Keratitis | 1 | 2015 | 241 | 0.030 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2012 | 105 | 0.030 |
Why?
|
| Umbilical Veins | 2 | 2004 | 425 | 0.030 |
Why?
|
| RNA, Viral | 3 | 2007 | 2871 | 0.030 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 11934 | 0.030 |
Why?
|
| Mesoderm | 1 | 2015 | 679 | 0.020 |
Why?
|
| alpha-Galactosidase | 1 | 2012 | 58 | 0.020 |
Why?
|
| Thymectomy | 2 | 2003 | 200 | 0.020 |
Why?
|
| Cross-Sectional Studies | 3 | 2020 | 26384 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2019 | 5035 | 0.020 |
Why?
|
| Oocytes | 1 | 2016 | 1172 | 0.020 |
Why?
|
| Hirudins | 1 | 2012 | 179 | 0.020 |
Why?
|
| Spermatogenesis | 1 | 2012 | 260 | 0.020 |
Why?
|
| Stomach | 1 | 2016 | 702 | 0.020 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2013 | 283 | 0.020 |
Why?
|
| Adenosine Diphosphate | 1 | 2012 | 422 | 0.020 |
Why?
|
| Cell Size | 1 | 2013 | 626 | 0.020 |
Why?
|
| Drug Approval | 1 | 2018 | 820 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2016 | 4168 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2019 | 1524 | 0.020 |
Why?
|
| Pandemics | 2 | 2022 | 8745 | 0.020 |
Why?
|
| Influenza, Human | 1 | 2022 | 1541 | 0.020 |
Why?
|
| Diffusion of Innovation | 1 | 2016 | 732 | 0.020 |
Why?
|
| Budesonide | 1 | 2012 | 162 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2016 | 1195 | 0.020 |
Why?
|
| Nurses | 1 | 2020 | 2501 | 0.020 |
Why?
|
| Cell-Derived Microparticles | 1 | 2012 | 161 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2016 | 1478 | 0.020 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2012 | 344 | 0.020 |
Why?
|
| Prothrombin | 1 | 2010 | 194 | 0.020 |
Why?
|
| Netherlands | 1 | 2015 | 2277 | 0.020 |
Why?
|
| Gastric Mucosa | 1 | 2013 | 602 | 0.020 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2011 | 239 | 0.020 |
Why?
|
| Implants, Experimental | 1 | 2009 | 99 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4593 | 0.020 |
Why?
|
| Cell Count | 1 | 2013 | 1833 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2015 | 1913 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2012 | 1990 | 0.020 |
Why?
|
| Survival Rate | 1 | 2003 | 12873 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 2862 | 0.020 |
Why?
|
| Tretinoin | 1 | 2012 | 525 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2023 | 12469 | 0.020 |
Why?
|
| Endosonography | 1 | 2013 | 626 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2010 | 605 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2460 | 0.020 |
Why?
|
| Zoonoses | 1 | 2009 | 180 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2017 | 2149 | 0.020 |
Why?
|
| Research Design | 1 | 2024 | 6213 | 0.020 |
Why?
|
| Antioxidants | 1 | 2016 | 1673 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2012 | 1762 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2014 | 1112 | 0.020 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2019 | 1483 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2019 | 2724 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 1973 | 0.020 |
Why?
|
| Fluorescence | 1 | 2009 | 758 | 0.020 |
Why?
|
| New South Wales | 1 | 2007 | 69 | 0.020 |
Why?
|
| Palliative Care | 1 | 2022 | 3644 | 0.020 |
Why?
|
| Dithioerythritol | 1 | 2006 | 8 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 2018 | 2783 | 0.020 |
Why?
|
| Sheep | 1 | 2009 | 1451 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 2635 | 0.020 |
Why?
|
| Benzoates | 1 | 2008 | 213 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 5544 | 0.020 |
Why?
|
| Critical Care | 1 | 2019 | 2715 | 0.020 |
Why?
|
| Pain | 1 | 2021 | 5100 | 0.020 |
Why?
|
| Haplorhini | 1 | 2006 | 524 | 0.020 |
Why?
|
| Lipodystrophy | 1 | 2007 | 145 | 0.020 |
Why?
|
| Cell Shape | 1 | 2007 | 371 | 0.020 |
Why?
|
| Pediatrics | 1 | 2020 | 3628 | 0.020 |
Why?
|
| Th17 Cells | 1 | 2012 | 791 | 0.020 |
Why?
|
| Thiazoles | 1 | 2012 | 1542 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2006 | 1142 | 0.020 |
Why?
|
| Heparin | 1 | 2012 | 1636 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2016 | 3138 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 3518 | 0.010 |
Why?
|
| Plant Lectins | 1 | 2004 | 103 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 20244 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2008 | 1751 | 0.010 |
Why?
|
| Collagen | 1 | 2012 | 2646 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 2004 | 0.010 |
Why?
|
| Hematopoietic System | 1 | 2004 | 110 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2007 | 1162 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2007 | 818 | 0.010 |
Why?
|
| Morbidity | 1 | 2008 | 1757 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 3110 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2012 | 3659 | 0.010 |
Why?
|
| Chimera | 1 | 2004 | 454 | 0.010 |
Why?
|
| Inclusion Bodies, Viral | 1 | 2002 | 45 | 0.010 |
Why?
|
| Leukapheresis | 1 | 2002 | 150 | 0.010 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2002 | 130 | 0.010 |
Why?
|
| Perforin | 1 | 2002 | 167 | 0.010 |
Why?
|
| Receptors, CCR2 | 1 | 2003 | 216 | 0.010 |
Why?
|
| Cell Communication | 1 | 2008 | 1660 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2008 | 1541 | 0.010 |
Why?
|
| Comorbidity | 1 | 2016 | 10591 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2002 | 225 | 0.010 |
Why?
|
| Genes, Viral | 1 | 2002 | 655 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2008 | 2204 | 0.010 |
Why?
|
| Cell Line | 1 | 2014 | 15603 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2004 | 1609 | 0.010 |
Why?
|
| Weight Loss | 1 | 2012 | 2720 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2018 | 22294 | 0.010 |
Why?
|
| Diet | 1 | 2017 | 8090 | 0.010 |
Why?
|
| Creatinine | 1 | 2004 | 1917 | 0.010 |
Why?
|
| Mitochondria | 1 | 2012 | 3683 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2005 | 2525 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2002 | 1133 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2008 | 2139 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2002 | 1027 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2002 | 15662 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2008 | 3465 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 6232 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2006 | 2260 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 7609 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 20776 | 0.010 |
Why?
|
| Pneumonia | 1 | 2002 | 2163 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2007 | 13054 | 0.000 |
Why?
|
| Pregnancy | 1 | 2009 | 30175 | 0.000 |
Why?
|
| Chronic Disease | 1 | 2002 | 9384 | 0.000 |
Why?
|